On the morning of the first session of the 2025 National Negotiation, 6 pharmaceutical companies have completed negotiations and exited, involving products including analgesics and anti-infectives

On October 30th, reporters learned from the on-site negotiations for the 2025 National Medical Insurance Catalog and the price negotiations for innovative drugs under commercial insurance that the representatives of companies entering the venue this morning included Haisco, Yifan Pharmaceutical, Astrazeneca, CSPC PHARMA, LUYE PHARMA, and several other pharmaceutical companies. It is estimated that the varieties involved include multiple medications such as analgesics and anti-infectives. Around 9:30, the first batch of negotiation representatives completed their negotiations and left the venue in order. The reporter noted that the Astrazeneca negotiation representative was still Astrazeneca Vice President Huang Bin, who left the venue smiling and wearing the iconic red scarf around 9:36